🔴 Decoy Therapeutics is trading 6.8% down in pre-market with no company-specific catalyst identified

Decoy Therapeutics is trading at $2.88, down 6.80%, with no fresh company-specific catalyst identified for the September 28 pre-market drop.

• Broader risk-off sentiment, including higher oil and Treasury yields and weaker U.S. futures, may be contributing. The White House rejected Iran’s ceasefire proposal, renewing geopolitical and energy concerns.
• Recent financing news reported $3.85 million in gross proceeds from warrant exercises, reduced warrant exercise prices and new warrants. It predates this session and does not establish the cause of the move.